We report on the long‐term intention‐to‐treat (ITT) outcome of 118 patients with hepatocellular
carcinoma (HCC) undergoing downstaging to within Milan/United Network for Organ …

Direct‐acting antiviral (DAA) therapy, recently approved for patients with decompensated
cirrhosis (DC) secondary to hepatitis C virus (HCV), is associated with improved hepatic …

BACKGROUND All patients with cirrhosis are at risk of developing hepatocellular carcinoma
(HCC). This risk is not uniform because other patient‐related factors influence the risk of …

Background and Aims Mortality secondary to cirrhosis in North America is increasing. We
describe the incidence of cirrhosis stratified by birth cohort and cirrhosis etiology and project …

Background To evaluate screening and treatment strategies, large-scale real-world data on
liver disease-related outcomes are needed. We sought to validate health administrative data …

Background Recent data show that the prevalence of chronic liver disease and cirrhosis is
increasing in adolescents and young adults in the USA. We aimed to describe the …

Background & Aims The incidence of cirrhosis is increasing among women of childbearing
age. Contemporary outcomes of pregnant women with cirrhosis and their infants, as well as …

Patients with primary biliary cholangitis (PBC) with incomplete response to ursodeoxycholic
acid are at risk of disease progression and need additional therapy. Obeticholic acid (OCA) …

Background & Aims With the World Health Organization plan for hepatitis C elimination by the
year 2030, and recent guideline recommendations to screen all women during pregnancy …

The present series of experiments assessed how information from the whiskers controls and
modulates infant rat behavior during early learning and attachment. Passive vibrissal …